UnknownNot Applicable

Prevalence of HBV in Pregnancy

Egypt200 participantsStarted 2022-06-15

Plain-language summary

The most common mode of HBV transmission is materno-fetal transmission mainly during labor. This study aims to estimate the seroprevalence of HBV infection and the possible risk factors of HBV acquisition in pregnant women in Upper Egypt and to evaluate the predictive value of HBeAg and quantitative HBsAg as surrogate markers for high viremia in pregnant women.

Who can participate

Age range16 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all pregnant women Exclusion Criteria: \-

What they're measuring

HBsAg

Timeframe: 6 months

Risk factors of HBV in pregnancy

Timeframe: 6 months

Trial details

NCT IDNCT05442372

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-02-15

Contact for this trial

Amira Maher, MD

01006789652 amiramaher@med.sohag.edu.eg

View on ClinicalTrials.gov More Hepatitis B trials